wei huang

Dr. wei huang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Seminars in Hematology
Verified
Journal Article
Open access
HWHan Wang
Han Wang
JGJia Gu
Jia Gu
XLXue Liang
Xue Liang
XMXiao Mao
Xiao Mao
ZWZhiqiong Wang
Zhiqiong Wang
WHwei huang
wei huang
Hemophagocytic lymphohistiocytosis (HLH) is an immune-mediated syndrome resulting in cytokine storm. The uncontrolled cytokine storm leads to significant tissue damage and potentially life-threatening multi-organ failure. Conventional first-line treatment for HLH included HLH-94 protocol or HLH-2004 protocol. However, up to 30% of patients do not respond to first-line therapy. We reported three cases of secondary HLH/MAS which were caused by lymphoma (two cases) and adult-onset still's disease(AOSD). They received low dose ruxolitinib plus HLH-94 protocol, and had rapid response to treatment without obvious adverse effects. Following the treatment, there was improvement seen in several disease markers, including fever, fibrinogen, serum ferritin, and liver function tests. Our report indicated that treatment with low dose ruxolitinib plus HLH-94 protocol might be a potential choice for secondary HLH, and clinical trials warrants to be further investigated in this treatment regimen.

1 January 2023 in Clinical & Translational Immunology
Verified
Journal Article
Open access
KSKefeng Shen
Kefeng Shen
JWJiachen Wang
Jiachen Wang
KZKuangguo Zhou
Kuangguo Zhou
WMWei Mu
Wei Mu
MZMeilan Zhang
Meilan Zhang
MXMin Xiao
Min Xiao
Objectives: Increasing evidence indicates that some germline genetic mutations that impair pathways required for robust host immune surveillance against EBV infection may result in an extremely high susceptibility to EBV‐associated lymphoproliferative disease (EBV+ LPD). TNFRSF9 encodes a vital costimulatory molecule that enhances CD8+ T‐cell proliferation, survival and cytolytic activity. To date, no relevant case resulting from TNFRSF9 heterozygous mutations has been identified.Methods: Here, we report the first case of CD137 deficiency caused by two novel biallelic heterozygous TNFRSF9 mutations [NM_001561.5: c.208 + 1−>AT and c.452C>A (p.T151K)] in a patient presenting with severe EBV+ LPD. Immunophenotyping and in vitro assays of lymphocyte function and NK cell activity were performed.Results: Biallelic TNFRSF9 mutations resulted in markedly reduced or abrogated expression of CD137 on activated T, B and NK cells. CD8+ T cells from the patient had impaired activation, reduced expression/release of interferon‐γ (IFN‐γ), tumor necrosis factor‐α (TNF‐α), perforin and granzyme B, and diminished cytotoxic activity. Functional experiments identified both variations were hypomorphic mutations and played a contributing role in CD137 deficiency and the development of EBV+ LPD.Conclusion: Our study expands the genetic spectrum and clinical phenotype of patients with CD137 deficiency and provides additional evidence that the TNFRSF9 gene plays a critical role in host immune responses to EBV infection.

26 September 2023 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
KZKuangguo Zhou
Kuangguo Zhou
DGDuanhao Gong
Duanhao Gong
YHYunfeng Han
Yunfeng Han
WHwei huang
wei huang

21 February 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JGJia Gu
Jia Gu
TLTongJuan Li
TongJuan Li
LZLei Zhao
Lei Zhao
XLXue Liang
Xue Liang
XFXing Fu
Xing Fu
JZJianfeng Zhou
Jianfeng Zhou
PAX5 encodes a transcription factor essential for B-cell differentiation, and PAX5 haploinsufficiency is involved in tumorigenesis. There were few studies on how PAX5 haploinsufficiency regulated genes expression to promote tumorigenesis. In this study, we constructed the cell model of PAX5 haploinsufficiency using gene editing technology in Raji cells, detected differentially expressed genes in PAX5 haploinsufficiency Raji cells, and used protein-protein interaction networks and cluster analysis to comprehensively investigate the cellular pathways involved in PAX5 haploinsufficiency. The clusters of gene transcription, inflammatory and immune response, and cancer pathways were identified as three important pathways associated with PAX5 haploinsufficiency in Raji cells. These changes hinted that the mechanism of PAX5 haploinsufficiency promoting tumorigenesis may be related to genomic instability, immune tolerance, and tumor pathways.

1 June 2018 in Experimental Cell Research
Verified
Journal Article
Closed access
XLXue Liang
Xue Liang
JGJia Gu
Jia Gu
TLTongJuan Li
TongJuan Li
LZLei Zhao
Lei Zhao
XFXing Fu
Xing Fu
JZJianfeng Zhou
Jianfeng Zhou

10 April 2023 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
KZKuangguo Zhou
Kuangguo Zhou
DGDuanhao Gong
Duanhao Gong
CHCheng He
Cheng He
MXMin Xiao
Min Xiao
MZMeilan Zhang
Meilan Zhang
WHwei huang
wei huang